Krystexxa (Horizon Pharma Inc.)


Welcome to the PulseAid listing for the Krystexxa drug offered from Horizon Pharma Inc.. This Urate Oxidase [Chemical/Ingredient],Uric Acid-specific Enzyme [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Horizon Pharma Inc.
NON-PROPRIETARY NAME: pegloticase
SUBSTANCE NAME: PEGLOTICASE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Urate Oxidase [Chemical/Ingredient],Uric Acid-specific Enzyme [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2010-09-14
END MARKETING DATE: 0000-00-00


Krystexxa HUMAN PRESCRIPTION DRUG Details:

Item DescriptionKrystexxa from Horizon Pharma Inc.
LABELER NAME: Horizon Pharma Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 8(mg/mL)
START MARKETING DATE: 2010-09-14
END MARKETING DATE: 0000-00-00
PRODUCT ID: 75987-080_c8958f99-0e87-406d-97e0-1346139f32e8
PRODUCT NDC: 75987-080
APPLICATION NUMBER: BLA125293

Other PEGLOTICASE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Crealta Pharmaceuticals LLCKrystexxa
Horizon Pharma Inc.Krystexxa
Savient Pharmaceuticals, Inc.Krystexxa